ÂÜÀòÂÒÂ×

Perry Linz is a Principal Scientist at HUVEPHARMA, INC since October 2022, specializing in the design and evaluation of vaccine candidates for poultry and swine. Previously, Perry held roles at Curtiss Healthcare, Inc. as Lead Project Manager and Sr. Scientist, Program Lead, where responsibilities included coordinating licensure activities and optimizing Marek’s Disease vaccines. Perry's career began at Intervet Inc. and included positions at Intervet/Schering-Plough Animal Health and Merial Inc., focusing on the development of recombinant vector vaccines and bacterial poultry vaccines. Educational qualifications include a Master's degree in Biotechnology from The Johns Hopkins University and a Bachelor's degree in Microbiology from Salisbury State University.